Thank you for the question.
I would say that we are not talking about eliminating confidentiality. Canada has a very comprehensive regime for managing the confidentiality of the data that is provided to them by applicants in their process for chemicals assessments and management. What we are seeking, and what the government broadly is seeking in its own policy lab process, is transparency and looking for models of how to bring forward supply chain transparency.
I think labelling is only one piece of the puzzle in terms of disclosing ingredients. As I mentioned before, in the EU and in California, companies are disclosing and labelling at a much higher standard than what we are currently seeing in Canada.
We also heard from our colleague, Dr. Pétrin-Desrosiers, about endocrine-disrupting substances and the leadership that other jurisdictions are taking to ensure that people are able to avoid exposures during critical windows of development if possible.